Bio-Rad Laboratories Inc logo

Bio-Rad Laboratories Inc

$ 418.65 0 (0%) 09:40 AM EST
On watch
P/E:
At Loss
P/B:
1.50
Market Cap:
$ 13.19B
Enterprise V:
$ 12.61B
Volume:
-
Avg Vol (2M):
407.00
Also Trade In:
Volume:
-
Market Cap $:
13.19B
PE Ratio:
At Loss
Avg Vol (2-Month):
407.00
Enterprise Value $:
12.61B
PB Ratio:
1.50
GF Score:
Year:
To
10Y: -%
Above Low: +NaN%
Below High: NaN%
Alerts Website SEC Filings Stock Report
Dataset
Financial Download

Business Description

Description
Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and markets products and solutions for the clinical diagnostics and life sciences markets. In diagnostics (53% of sales), Bio-Rad manufactures, sells, and supports test systems and specialized quality controls for clinical laboratories. In life sciences (47% of sales), the firm develops and manufactures a range of instruments and reagents used in research, biopharmaceutical production, and food testing. The company is geographically diverse, with major markets in the Americas (42% of 2021 sales), Europe and Africa (33%), and Asia-Pacific (25%). Bio-Rad owns 37% of Sartorius AG, a laboratory and biopharmaceutical supplier.
Name Current Vs Industry Vs History
Cash-To-Debt 1.41
Equity-to-Asset 0.7
Debt-to-Equity 0.16
Debt-to-EBITDA -0.57
Interest Coverage 33.26
Piotroski F-Score 5/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 2.92
Distress
Grey
Safe
Beneish M-Score -2.84
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 5.98
9-Day RSI 6.65
14-Day RSI 9.88
6-1 Month Momentum % -11.68
12-1 Month Momentum % -29.69

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 5.3
Quick Ratio 4.22
Cash Ratio 3.21
Days Inventory 178.96
Days Sales Outstanding 54.79
Days Payable 43.26

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -0.1

Financials (Next Earnings Date:2022-10-28 Est.)

BIO.B's 30-Y Financials

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with NYSE:BIO.B

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
To

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

Valuation Box

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 2,870.979
EPS (TTM) ($) -66.32
Beta 0.68
Volatility % 29.63
14-Day RSI 9.88
14-Day ATR ($) 4.453656
20-Day SMA ($) 465.968
12-1 Month Momentum % -29.69
52-Week Range ($) 418.65 - 784.4
Shares Outstanding (Mil) 29.7

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 5
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Bio-Rad Laboratories Inc Filings

Document Form Filing Date
No Filing Data

Bio-Rad Laboratories Inc Analysis

Share your research

Headlines

See More
No news.